Form 4 for NVCT Nuvectis Pharma, Inc.
Accepted 2022-05-23 00:00:00 ET · period of report 2022-05-19 · accession 0001104659-22-063645 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-05-23 | 2022-05-19+ | NVCT | BENTSUR RON | COB, CEO, Dir, 10% | P - Purchase | $16.73 | +1,200 | 2.96M | +0.0% | +$20.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-20 | P | A | 1,000 | $16.28 | 2,962,614 | D | — | — | (F1) Includes 96,759 shares of restricted stock and 120,000 restricted stock units. |
| 2 | Common | Common Stock | 2022-05-19 | P | A | 200 | $18.95 | 2,961,614 | D | — | — | (F1) Includes 96,759 shares of restricted stock and 120,000 restricted stock units. |